|Mr. Alvaro Francisco Torres||Co-Founder, CEO & Director||N/A||N/A||1979|
|Ms. Wendy Kaufman C.A., CPA, CPA||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Vicente Fox||Strategic Advisor & Director||N/A||N/A||1943|
|Mr. Andres Galofre||Co-Founder & VP of Bus. Devel.s||N/A||N/A||1982|
|Mr. Manuel Buendia||VP of Operations||N/A||N/A||N/A|
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; and develops CBD-based cosmeceutical products under the Kuida brand name. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.
Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.